News Releases

Date Title  
Toggle Summary Adamis Pharmaceuticals Prevails in License Dispute Litigation
SAN DIEGO ,  Feb. 28, 2013  /PRNewswire/ --  Adamis Pharmaceuticals Corporation  (OTCQB: ADMP), a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease,
Adamis Pharmaceuticals Prevails in License Dispute Litigation
SAN DIEGO ,  Feb. 28, 2013  /PRNewswire/ --  Adamis Pharmaceuticals Corporation  (OTCQB: ADMP), a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease,